This is the way we're going for patients with HIV (who are) starting therapy for the first time. It's becoming very easy and safe and effective.

There is nothing new about turning science into politics. This has been going on for some time in this administration.

We should get that down to one pill by the end of the year. It's very impressive.

This is telling me, personally, that something is wrong. But we still have to see what happens later.

This is the recommended therapy for all patients. We get 100 percent of our patients on it.

We are very excited that this simple and inexpensive therapy turned out to be so effective and well-tolerated in patients with CF. It is especially gratifying to see patients in our own clinical practice embrace and benefit from it.